Cancer subtypes classification using long non-coding RNA - Sorbonne Université Access content directly
Journal Articles Oncotarget Year : 2016

Cancer subtypes classification using long non-coding RNA


Inter-tumor heterogeneity might explain divergent clinical evolution of cancers bearing similar pathological features. In the last decade, genomic has highly improved tumor subtypes classification through the identification of oncogenic or tumor suppressor drivers. In addition, epigenetics and long non-coding RNAs (lncRNAs) are emerging as new fields for investigation, which might also account for tumor heterogeneity. There is growing evidence that modifications of lncRNA expression profiles are involved in cancer progression through epigenetic regulation, activation of pro-oncogenic pathways and crosstalks with other RNA subtypes. Consequently, the study of lncRNA expression profile will be a key factor in the future for charting cancer subtype classifications as well as defining prognostic and progression biomarkers. Herein we discuss the interest of lncRNA as potent prognostic and predictive biomarkers, and provide a glimpse on the impact of emerging cancer subtypes classification based on lncRNAs.


Fichier principal
Vignette du fichier
10213-155459-4-PB.pdf (1.35 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-01419223 , version 1 (19-12-2016)





Ronan Flippot, Gabriel G. Malouf, Xiaoping Su, Roger Mouawad, Jean-Philippe Spano, et al.. Cancer subtypes classification using long non-coding RNA. Oncotarget, 2016, 7 (33), pp.54082-54093. ⟨10.18632/oncotarget.10213⟩. ⟨hal-01419223⟩
63 View
217 Download



Gmail Facebook X LinkedIn More